A landmark moment for cancer care in western India: Union Health Minister J. P. Nadda on Monday, November 2, 2026 declared the commissioning of an advanced radiotherapy facility at AIIMS Rajkot a historic achievement — for Gujarat and for the country's broader fight against cancer. In a post on X, Nadda wrote in Hindi: 'AIIMS राजकोट में एडवांस्ड रेडियोथेरेपी सुविधा की स्थापना गुजरात और कैंसर उपचार के क्षेत्र में एक ऐतिहासिक उपलब्धि है' — ('The establishment of an advanced radiotherapy facility at AIIMS Rajkot is a historic achievement in the field of Gujarat and cancer treatment.') He added that the technology will make cancer treatment 'more precise, safe, and effective', and credited Prime Minister Narendra Modi's 'visionary thinking and leadership' for the initiative.

What the Rajkot Radiotherapy Unit Changes for Gujarat Patients

For cancer patients across Gujarat and neighbouring regions, the stakes are immediate. Until now, patients requiring high-precision radiotherapy — a treatment that targets tumours with tightly focused radiation beams to minimise damage to surrounding tissue — often had to travel hundreds of kilometres to older, better-equipped centres in metros. A functional radiotherapy unit at AIIMS Rajkot collapses that distance. Faster access to treatment matters enormously in oncology: delayed radiotherapy can directly affect survival outcomes. The addition is consistent with a deliberate national pattern. As new AIIMS campuses move from construction to clinical operation, the Health Ministry has been progressively commissioning specialised units — oncology, cardiac care, advanced imaging — to transform these institutes from basic referral points into full-spectrum tertiary centres.

AIIMS Rajkot and the Pradhan Mantri Swasthya Suraksha Yojana

AIIMS Rajkot is one of the newest nodes in India's expanding public tertiary-care network, established under the Pradhan Mantri Swasthya Suraksha Yojana (PMSSY) — a central scheme first launched in 2003 to correct sharp regional imbalances in access to advanced hospital care. The scheme's core logic was blunt: too much specialist capacity was concentrated in a handful of older AIIMS, forcing patients from states like Gujarat, Jharkhand, and Himachal Pradesh into long, costly journeys for procedures available nowhere near home. Over successive governments, the AIIMS network has grown well beyond its original five campuses. The Rajkot facility represents that expansion reaching deep into Gujarat — a large, economically significant state that had historically lacked a central-government-run apex medical institution of this scale.

Cancer Care as a Measure of a New AIIMS Coming of Age

Radiotherapy infrastructure is, in a real sense, a test of whether a new AIIMS has matured. The equipment is expensive, its operation demands certified physicists and radiation oncologists, and its commissioning signals that a campus has moved past bare-bones functionality. The Rajkot unit clears that bar. Nadda's framing — attributing the achievement directly to the Prime Minister's 'foresight' — also signals how the Health Ministry is positioning the AIIMS expansion politically: as a flagship of the Modi government's health equity agenda ahead of what remains a crowded policy calendar. For the patients who will walk through AIIMS Rajkot's oncology doors, the politics matter far less than the machine that is now switched on.